SCHEMBL6311362

SCHEMBL6311362

CCOC(=O)C(=O)Nc1scc(-c2ccccc2)c1C(=O)OCC

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 9/20 0.71
GSTO1 P78417 1/20 0.71
SMN1; SMN2 Q16637 8/20 0.70
ALDH1A1 P00352 7/20 0.70
MAPT P10636 6/20 0.70
MEN1 O00255 6/20 0.70
KMT2A Q03164 6/20 0.70
ALOX12 P18054 3/20 0.70
HTT P42858 2/20 0.70
POLB P06746 4/20 0.69
RAB9A P51151 1/20 0.69
PTPN1 P18031 3/20 0.67
PTPRC P08575 1/20 0.67
PTPRF P10586 1/20 0.67
PTPN2 P17706 1/20 0.67
PTPA Q15257 1/20 0.67
L3MBTL1 Q9Y468 1/20 0.67
KDM4E B2RXH2 3/20 0.64
HPGD P15428 3/20 0.64
NPSR1 Q6W5P4 2/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27558689 0.91 GSTO1 (0.63) LMNAGSTO1SMN1; SMN2ALDH1A1MAPT
SCHEMBL11634946 0.88 LMNA (0.74) LMNAGSTO1SMN1; SMN2ALDH1A1MAPT
SCHEMBL23580345 0.86 LMNA (0.73) LMNAGSTO1SMN1; SMN2ALDH1A1MAPT
SCHEMBL9396589 0.85 LMNA (0.79) LMNAGSTO1SMN1; SMN2ALDH1A1MAPT
SCHEMBL23599197 0.85 LMNA (0.74) LMNAGSTO1SMN1; SMN2ALDH1A1MAPT
SCHEMBL2981645 0.84 LMNA (0.79) LMNAGSTO1SMN1; SMN2ALDH1A1MAPT
SCHEMBL5804336 0.84 POLB (0.74) LMNAGSTO1SMN1; SMN2ALDH1A1MAPT
SCHEMBL5804332 0.84 POLB (0.74) LMNAGSTO1SMN1; SMN2ALDH1A1MAPT
SCHEMBL2897094 0.84 POLB (0.74) LMNAGSTO1SMN1; SMN2ALDH1A1MAPT
SCHEMBL23579845 0.83 POLB (0.72) LMNAGSTO1SMN1; SMN2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050119332-A1 Substituted thiophene compounds as modulators of protein tyrosine phosphatases (PTPases) JEPPESEN LONE (DK) 2005-06-02 US disclosed
US-20020165398-A1 Modulators of protein tyrosine phosphatases (PTPases) JEPPESEN LONE (DK) 2002-11-07 US disclosed
US-20020002199-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 2002-01-03 US disclosed
EP-1080068-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES Novo Nordisk A/S (DK) 2001-03-07 EP disclosed
EP-1062204-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 2000-12-27 EP disclosed
WO-1999046244-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 1999-09-16 WO disclosed
WO-1999046237-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES NOVO NORDISK A/S (DK) 1999-09-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020165398-A1 Modulators of protein tyrosine phosphatases (PTPases) PTPRCAP, PTPRS, PTPRO LMNA 4790/4885GSTO1 4077/4885SMN1; SMN2 1660/4885
US-20020002199-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) PTPRCAP, PTPRS, PTPRA LMNA 4783/4885GSTO1 4079/4885SMN1; SMN2 1576/4885
US-20050119332-A1 Substituted thiophene compounds as modulators of protein tyrosine phosphatases (PTPases) PTPRCAP, PTPRS, PTPN1 LMNA 4870/4885GSTO1 2855/4885SMN1; SMN2 1880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.